Novavax (NVAX)
Builds protein vaccines and Matrix-M partnerships around Nuvaxovid and R21/Matrix-M.
$10.93
vs last close+0.52 (+5.00%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 72.00% | 118.76M shares | |
|---|---|---|---|
| 298 holders · as of Jun 30, 2026 | |||
| Insiders | 9.67% | 15.95M shares | |
| 17 holders · as of Jun 23, 2026 | |||
| Other | 18.33% | 30.24M shares | |
| remainder | |||
164.95M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
298 holders · 118.76M shares · 44 new positions · 123 increased · 83 reduced · 34 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Shah Capital Management | 14.17M | 8.59% | −679.5K | Aug 14, 2026 |
| BlackRock, Inc. | 13.95M | 8.46% | +1.10M | Aug 7, 2026 |
| State Street Corp | 11.74M | 7.12% | +2.77M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 7.61M | 4.61% | +456.4K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 7.26M | 4.40% | +127.3K | Aug 13, 2026 |
| Sanofi | 6.88M | 4.17% | 0 | Jul 28, 2026 |
| D. E. Shaw & Co., Inc. | 5.65M | 3.43% | −2.06M | Aug 14, 2026 |
| Geode Capital Management, LLC | 4.21M | 2.55% | +309.0K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Himanshu H. Shahincl. Shah Capital Opportunity Fund LP, Shah Capital Management | 9.03% | 14.84M | 13D | May 15, 2026 |
| BlackRock, Inc. | 8.40% | 13.45M | 13G | Feb 5, 2025 |
| State Street Corporation | 7.10% | 11.74M | 13G | Aug 7, 2026 |
| Vanguard Capital Management | 5.09% | 8.31M | 13G | Apr 30, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.